RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
 ALNY | Alnylam Pharmaceuticals, Inc. | $40.3b | $301.56 | +2.0% | 76.0K |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $12.6b | $81.81 | +2.7% | 493.3K |
 ARWR | Arrowhead Research Corporation | $11.0b | $80.70 | +0.1% | 137.3K |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $1.3b | $6.01 | +3.7% | 223.2K |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $228.0m | $4.20 | +3.3% | 26.2K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $222.4m | $12.90 | 0.0% | 4.2K |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $221.5m | $9.31 | +0.3% | 7.9K |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $166.5m | $1.58 | -2.2% | 242.3K |
 XCUR | Exicure, Inc. Common Stock | $20.3m | $2.67 | 0.0% | 17.8K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $12.9m | $0.99 | 0.0% | 20.6K |